A 32-year-old woman from Mumbai with PCOS and secondary infertility (1-year duration) presents for ovulation induction. She has irregular cycles (35–60 days), elevated LH/FSH ratio (3.2), and normal prolactin. Previous trial of clomiphene citrate 100 mg daily (day 3–7) for 3 cycles resulted in no follicular development on ultrasound. What is the most appropriate next step?

Explanation

## Clinical Context **Patient Profile:** - PCOS confirmed (irregular cycles, elevated LH/FSH ratio) - Clomiphene-resistant (no response at 100 mg × 3 cycles) - Normal prolactin (excludes hyperprolactinemia) - Secondary infertility (has conceived before) ## Diagnosis: Clomiphene-Resistant PCOS **Key Point:** Clomiphene resistance in PCOS occurs in ~20–30% of cases due to: - Increased androgen production suppressing FSH-responsive follicles - Impaired endometrial development (anti-estrogenic effect) - Thick ovarian capsule limiting follicle emergence ## Management Algorithm ```mermaid flowchart TD A[PCOS with infertility]:::outcome --> B[First-line: Clomiphene citrate 50-100 mg]:::action B --> C{Response?}:::decision C -->|Yes: Ovulation| D[Continue, monitor]:::action C -->|No: Clomiphene-resistant| E[Switch to Letrozole]:::action E --> F{Response?}:::decision F -->|Yes| G[Proceed with IUI/timed intercourse]:::action F -->|No| H[Gonadotropins ± GnRH agonist]:::action H --> I[Ovarian drilling if all else fails]:::action ``` ## Why Letrozole Is Second-Line in CC-Resistant PCOS | Parameter | Clomiphene | Letrozole | Gonadotropins | |-----------|-----------|-----------|---------------| | **Mechanism** | SERM (↑ FSH) | Aromatase inhibitor (↓ estrogen) | Direct FSH/LH | | **Androgen effect** | ↑ Androgens (bad in PCOS) | ↓ Androgens (good) | Neutral | | **Endometrial thickness** | ↓ (anti-estrogenic) | Normal/↑ | Normal | | **Ovulation rate (PCOS)** | 60–70% | 75–80% | >90% | | **Cost** | Low | Low | High | | **First-line in PCOS** | Yes | Yes (if CC-resistant) | No (3rd-line) | **High-Yield:** Letrozole is superior to clomiphene in PCOS because: 1. Reduces intra-ovarian androgens → better FSH sensitivity 2. Preserves endometrial thickness (no anti-estrogenic effect) 3. Higher ovulation and pregnancy rates in CC-resistant PCOS 4. Lower cost than gonadotropins **Clinical Pearl:** Letrozole 2.5 mg daily for 5 days (day 3–7) is the standard dose. Ovulation typically occurs 7–10 days after the last dose. Ultrasound monitoring is essential to confirm follicle development and prevent OHSS. **Mnemonic:** **LEGO** — Letrozole for Estrogen reduction, Good in PCOS, Ovulation induction **Warning:** Do NOT increase clomiphene beyond 100 mg in PCOS — higher doses worsen androgen levels and endometrial atrophy without improving ovulation. Gonadotropins are reserved for letrozole failure or when IVF is planned.